Medifirst Pharma Private Limited

Medifirst Pharma Private Limited - pharma in Nashik, Maharashtra, India. FY 2026 financials & compliance.
CIN U33309MH2020PTC343694 Incorporated 12 August 2020 ROC Mumbai HQ Nashik, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2021
₹5.99 Lakh
Latest filing
Net profit · FY 2021
₹23,625
Net margin 3.9%
EBITDA · FY 2021
₹54,385
EBITDA margin 9.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings

About Medifirst Pharma Private Limited

Data last updated:

Medifirst Pharma Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 August 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33309MH2020PTC343694.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep Bhagwant Gulve and Janhavi Sandeep Gulve.

Its last annual general meeting (AGM) was held on 25 December 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Flat No.. 3 Shriyog Compex Nrraj Sarathi Society Indira Nagar, Nashik, Maharashtra, India – 422009.

As per the financials filed for FY 2021, the company reported a revenue of ₹5.99 Lakh. For the same year it recorded a net profit of ₹23,625 (net margin 3.9%) and EBITDA of ₹54,385 (EBITDA margin 9.1%).

As per MCA filings, the company has open charges of ₹10 Lakh on record.

Medifirst Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0135048). For more details, the company can be reached via its website medifirst-pharma-pvt-ltd.business.site.

Company details

CIN U33309MH2020PTC343694
Registration Number 343694
Incorporation Date 12 August 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 December 2021
Date of Balance Sheet 31 March 2021
MSME Classification Micro
Udyam Registration UDYAM-MH-23-0135048

Recognitions & Rankings of Medifirst Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-MH-23-0135048

Contact details

Medifirst Pharma Private Limited's registered office is in Nashik, Maharashtra. Its website is medifirst-pharma-pvt-ltd.business.site. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No.. 3 Shriyog Compex Nrraj Sarathi Society Indira Nagar, Nashik, Maharashtra, India – 422009
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Medifirst Pharma Private Limited, buy the company report.

Comprehensive company report
Medifirst Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medifirst Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Medifirst Pharma Private Limited, buy the company report.

Financials of Medifirst Pharma Private Limited

FY 2021 filings available

Medifirst Pharma Private Limited reported revenue of ₹5.99 Lakh for FY 2021.

Revenue · FY 2021
₹5.99 Lakh
Net profit · FY 2021
₹23,625 margin 3.9%
EBITDA · FY 2021
₹54,385 margin 9.1%

Financial Statement Summary

MetricsFY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹5.99 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹54,385
Profit Before Tax
Tax Expense
Net Profit (PAT)₹23,625
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21
Profitability
EBITDA Margin9.1%
Net Profit Margin3.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medifirst Pharma Private Limited, buy the company report.

Board of directors of Medifirst Pharma Private Limited

Medifirst Pharma has 2 directors on record. No former directors are listed.

Auditor

Medifirst Pharma Private Limited is audited by GUNDETI NIRMAL & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
GUNDETI NIRMAL & COFY 2021138484W

Shareholding

The shareholding of Medifirst Pharma Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Medifirst Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Canara Bank₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Mar 2022100592305Canara Bank₹10 LakhOpen

To see the full charge records of Medifirst Pharma Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medifirst Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Medifirst Pharma Private Limited has 1 active EPFO establishment as of Apr 04, 2024.

Active EPFO establishments
1

GST

No GST registration is on our record for Medifirst Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Medifirst Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Janhavi Sandeep Gulve was appointed as Director on 12 Aug 2020.

Charges
A charge with Canara Bank of Rs. 10.00 Lakh registered on 31 Mar 2022 with Charge ID 100592305 was modified on 24 Mar 2023.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Lakh with Charge ID 100592305 was registered on 31 Mar 2022.
AGM
Medifirst Pharma Private Limited last Annual general meeting of members was held on 25 Dec 2021 as per latest MCA records.
Filing
Medifirst Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai.
Appointed
Janhavi Sandeep Gulve was appointed as Director.
Appointed
Sandeep Bhagwant Gulve was appointed as Director.
Incorporation
12 Aug 2020
Medifirst Pharma Private Limited was registered on 12 Aug 2020 with Roc Mumbai & aged 6 years 2 months as per MCA records.

Frequently asked questions

Medifirst Pharma is an active private limited company based in Nashik, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 August 2020 (6+ years old) and is registered under CIN U33309MH2020PTC343694.

Medifirst Pharma has 2 current directors:

The latest financial statements of Medifirst Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 25 December 2021. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Medifirst Pharma is U33309MH2020PTC343694. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medifirst Pharma was incorporated on 12 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.

Janhavi Sandeep Gulve was appointed as Director on 12 Aug 2020. Sandeep Bhagwant Gulve was appointed as Director on 12 Aug 2020.

Yes, Medifirst Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-23-0135048).

Medifirst Pharma can be reached through the website medifirst-pharma-pvt-ltd.business.site. Its registered office is in Nashik, Maharashtra, India.

The registered office of Medifirst Pharma is at Flat No.. 3 Shriyog Compex Nrraj Sarathi Society Indira Nagar, Nashik, Maharashtra, India – 422009.

Medifirst Pharma operates in the pharma industry, in the drug formulation and development segment.